The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Type 2 Diabetes-Global Market Insights and Sales Trends 2024
Synopsis
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
The global Type 2 Diabetes market size is expected to reach US$ 118340 million by 2029, growing at a CAGR of 8.8% from 2023 to 2029. The market is mainly driven by the significant applications of Type 2 Diabetes in various end use industries. The expanding demands from the Drugstore, Hospital and Others,, are propelling Type 2 Diabetes market. Insulins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the DPP-4 Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Type 2 Diabetes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Type 2 Diabetes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Type 2 Diabetes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Type 2 Diabetes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Type 2 Diabetes covered in this report include Novo Nordisk, Sanofi, Merck, Eli Lily, AstraZeneca, Astellas Pharma, Daiichi Sankyo, Biocon and Boehringer Ingelheim, etc.
The global Type 2 Diabetes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Global Type 2 Diabetes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Type 2 Diabetes market, Segment by Type:
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Global Type 2 Diabetes market, by Application
Drugstore
Hospital
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Type 2 Diabetes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Type 2 Diabetes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.
The global Type 2 Diabetes market size is expected to reach US$ 118340 million by 2029, growing at a CAGR of 8.8% from 2023 to 2029. The market is mainly driven by the significant applications of Type 2 Diabetes in various end use industries. The expanding demands from the Drugstore, Hospital and Others,, are propelling Type 2 Diabetes market. Insulins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the DPP-4 Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Type 2 Diabetes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Type 2 Diabetes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Type 2 Diabetes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Type 2 Diabetes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Type 2 Diabetes covered in this report include Novo Nordisk, Sanofi, Merck, Eli Lily, AstraZeneca, Astellas Pharma, Daiichi Sankyo, Biocon and Boehringer Ingelheim, etc.
The global Type 2 Diabetes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
Sanofi
Merck
Eli Lily
AstraZeneca
Astellas Pharma
Daiichi Sankyo
Biocon
Boehringer Ingelheim
Global Type 2 Diabetes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Type 2 Diabetes market, Segment by Type:
Insulins
DPP-4 Inhibitors
GLP-1 Receptor Agonists
SGLT-2 Inhibitors
Global Type 2 Diabetes market, by Application
Drugstore
Hospital
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Type 2 Diabetes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Type 2 Diabetes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Type 2 Diabetes Market Overview
1.1 Type 2 Diabetes Product Overview
1.2 Type 2 Diabetes Market Segment by Type
1.2.1 Insulins
1.2.2 DPP-4 Inhibitors
1.2.3 GLP-1 Receptor Agonists
1.2.4 SGLT-2 Inhibitors
1.3 Global Type 2 Diabetes Market Size by Type
1.3.1 Global Type 2 Diabetes Market Size Overview by Type (2018-2029)
1.3.2 Global Type 2 Diabetes Historic Market Size Review by Type (2018-2023)
1.3.3 Global Type 2 Diabetes Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Type 2 Diabetes Sales Breakdown by Type (2018-2023)
1.4.2 Europe Type 2 Diabetes Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Type 2 Diabetes Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Type 2 Diabetes Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Type 2 Diabetes Sales Breakdown by Type (2018-2023)
2 Global Type 2 Diabetes Market Competition by Company
2.1 Global Top Players by Type 2 Diabetes Sales (2018-2023)
2.2 Global Top Players by Type 2 Diabetes Revenue (2018-2023)
2.3 Global Top Players by Type 2 Diabetes Price (2018-2023)
2.4 Global Top Manufacturers Type 2 Diabetes Manufacturing Base Distribution, Sales Area, Product Type
2.5 Type 2 Diabetes Market Competitive Situation and Trends
2.5.1 Type 2 Diabetes Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Type 2 Diabetes Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Type 2 Diabetes as of 2022)
2.7 Date of Key Manufacturers Enter into Type 2 Diabetes Market
2.8 Key Manufacturers Type 2 Diabetes Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Type 2 Diabetes Status and Outlook by Region
3.1 Global Type 2 Diabetes Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Type 2 Diabetes Historic Market Size by Region
3.2.1 Global Type 2 Diabetes Sales in Volume by Region (2018-2023)
3.2.2 Global Type 2 Diabetes Sales in Value by Region (2018-2023)
3.2.3 Global Type 2 Diabetes Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Type 2 Diabetes Forecasted Market Size by Region
3.3.1 Global Type 2 Diabetes Sales in Volume by Region (2024-2029)
3.3.2 Global Type 2 Diabetes Sales in Value by Region (2024-2029)
3.3.3 Global Type 2 Diabetes Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Type 2 Diabetes by Application
4.1 Type 2 Diabetes Market Segment by Application
4.1.1 Drugstore
4.1.2 Hospital
4.1.3 Others
4.2 Global Type 2 Diabetes Market Size by Application
4.2.1 Global Type 2 Diabetes Market Size Overview by Application (2018-2029)
4.2.2 Global Type 2 Diabetes Historic Market Size Review by Application (2018-2023)
4.2.3 Global Type 2 Diabetes Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Type 2 Diabetes Sales Breakdown by Application (2018-2023)
4.3.2 Europe Type 2 Diabetes Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Type 2 Diabetes Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Type 2 Diabetes Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Type 2 Diabetes Sales Breakdown by Application (2018-2023)
5 North America Type 2 Diabetes by Country
5.1 North America Type 2 Diabetes Historic Market Size by Country
5.1.1 North America Type 2 Diabetes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Type 2 Diabetes Sales in Volume by Country (2018-2023)
5.1.3 North America Type 2 Diabetes Sales in Value by Country (2018-2023)
5.2 North America Type 2 Diabetes Forecasted Market Size by Country
5.2.1 North America Type 2 Diabetes Sales in Volume by Country (2024-2029)
5.2.2 North America Type 2 Diabetes Sales in Value by Country (2024-2029)
6 Europe Type 2 Diabetes by Country
6.1 Europe Type 2 Diabetes Historic Market Size by Country
6.1.1 Europe Type 2 Diabetes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Type 2 Diabetes Sales in Volume by Country (2018-2023)
6.1.3 Europe Type 2 Diabetes Sales in Value by Country (2018-2023)
6.2 Europe Type 2 Diabetes Forecasted Market Size by Country
6.2.1 Europe Type 2 Diabetes Sales in Volume by Country (2024-2029)
6.2.2 Europe Type 2 Diabetes Sales in Value by Country (2024-2029)
7 Asia-Pacific Type 2 Diabetes by Region
7.1 Asia-Pacific Type 2 Diabetes Historic Market Size by Region
7.1.1 Asia-Pacific Type 2 Diabetes Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Type 2 Diabetes Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Type 2 Diabetes Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Type 2 Diabetes Forecasted Market Size by Region
7.2.1 Asia-Pacific Type 2 Diabetes Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Type 2 Diabetes Sales in Value by Region (2024-2029)
8 Latin America Type 2 Diabetes by Country
8.1 Latin America Type 2 Diabetes Historic Market Size by Country
8.1.1 Latin America Type 2 Diabetes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Type 2 Diabetes Sales in Volume by Country (2018-2023)
8.1.3 Latin America Type 2 Diabetes Sales in Value by Country (2018-2023)
8.2 Latin America Type 2 Diabetes Forecasted Market Size by Country
8.2.1 Latin America Type 2 Diabetes Sales in Volume by Country (2024-2029)
8.2.2 Latin America Type 2 Diabetes Sales in Value by Country (2024-2029)
9 Middle East and Africa Type 2 Diabetes by Country
9.1 Middle East and Africa Type 2 Diabetes Historic Market Size by Country
9.1.1 Middle East and Africa Type 2 Diabetes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Type 2 Diabetes Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Type 2 Diabetes Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Type 2 Diabetes Forecasted Market Size by Country
9.2.1 Middle East and Africa Type 2 Diabetes Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Type 2 Diabetes Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Type 2 Diabetes Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novo Nordisk Type 2 Diabetes Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Type 2 Diabetes Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Type 2 Diabetes Products Offered
10.2.5 Sanofi Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Type 2 Diabetes Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Type 2 Diabetes Products Offered
10.3.5 Merck Recent Development
10.4 Eli Lily
10.4.1 Eli Lily Company Information
10.4.2 Eli Lily Introduction and Business Overview
10.4.3 Eli Lily Type 2 Diabetes Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lily Type 2 Diabetes Products Offered
10.4.5 Eli Lily Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Type 2 Diabetes Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AstraZeneca Type 2 Diabetes Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Astellas Pharma
10.6.1 Astellas Pharma Company Information
10.6.2 Astellas Pharma Introduction and Business Overview
10.6.3 Astellas Pharma Type 2 Diabetes Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Astellas Pharma Type 2 Diabetes Products Offered
10.6.5 Astellas Pharma Recent Development
10.7 Daiichi Sankyo
10.7.1 Daiichi Sankyo Company Information
10.7.2 Daiichi Sankyo Introduction and Business Overview
10.7.3 Daiichi Sankyo Type 2 Diabetes Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Daiichi Sankyo Type 2 Diabetes Products Offered
10.7.5 Daiichi Sankyo Recent Development
10.8 Biocon
10.8.1 Biocon Company Information
10.8.2 Biocon Introduction and Business Overview
10.8.3 Biocon Type 2 Diabetes Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Biocon Type 2 Diabetes Products Offered
10.8.5 Biocon Recent Development
10.9 Boehringer Ingelheim
10.9.1 Boehringer Ingelheim Company Information
10.9.2 Boehringer Ingelheim Introduction and Business Overview
10.9.3 Boehringer Ingelheim Type 2 Diabetes Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Boehringer Ingelheim Type 2 Diabetes Products Offered
10.9.5 Boehringer Ingelheim Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Type 2 Diabetes Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Type 2 Diabetes Industrial Chain Analysis
11.4 Type 2 Diabetes Market Dynamics
11.4.1 Type 2 Diabetes Industry Trends
11.4.2 Type 2 Diabetes Market Drivers
11.4.3 Type 2 Diabetes Market Challenges
11.4.4 Type 2 Diabetes Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Type 2 Diabetes Distributors
12.3 Type 2 Diabetes Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
